Clinical Trial Update: Efficacy of Humira in Behcet Patients With Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Humira (adalimumab) for efficacy in Behçet disease with arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Behçet Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Arthritis; Behcet | Phase 3 | Status: COMPLETED